Hyperkalaemia is defined as abnormally elevated levels of potassium in the blood, a serious condition in cardio-renal patients that can be responsible for cardiac arrhythmias leading to cardiac arrest and death, with a resulting mortality rate of up to 30%.
![Female scientist with test tubes](https://www.csl.com/-/media/shared/stock-images/gettyimages1191113984femalescientist.jpg?h=450&iar=0&w=1600&cropregion=0,173,1600,624&hash=CB676B97F2AB6578E96AA13979A7DCF3)
Nephrology
![Nephrology scientist](https://www.csl.com/-/media/shared/employee-photos/vifor/ta-nephrology-anca-associated-vasculitis.jpg?h=430&iar=0&w=768&cropregion=0,0,768,430&hash=3A23D858F7075DF8400E1DE4E4C7F9AC)
Our Nephrology Products
Through our innovative portfolio, we aim to improve the lives of CKD patients through a broad range of therapies focused on distinct comorbidities and complications across all stages of CKD. Our continued success is underpinned by a diversified portfolio of commercial products and a promising pipeline.
![Kidney Disease Patient Faizan](https://www.csl.com/-/media/shared/patients/vifor/faizan-story.jpg?h=430&iar=0&w=768&cropregion=0,0,768,430&hash=E260359E626184C01AD2ED80656619EE)
Patient Stories
Patients are at the center of everything we do and we are committed to identifying and supporting under-served therapeutic areas. By working closely with patients and integrating their voice across key areas of our business , we can develop solutions that benefit them in the best possible way and improve standards of care.
See Our Patient Stories